Trauma treatment continues to challenge even highly skilled clinicians, particularly when clients remain stuck despite established therapeutic approaches. A growing body of research is exploring how psychedelics may influence processes relevant to trauma, including emotional processing, fear-based rigidity, and neuroplasticity when used within structured frameworks.
NIH-referenced studies indicate potential relevance for PTSD by reducing amygdala responsiveness during emotional processing, alongside acute effects such as increased emotional empathy, greater insightfulness, and improvements in psychological acceptance [1].
As interest grows in approaches involving psychedelics, therapists are increasingly asked to understand not only outcomes, but also the underlying mechanisms and clinical implications of these approaches.
What You'll Learn:
- How psychedelics interact with trauma-related neurobiology and memory processing
- Key findings from current research on consciousness-based interventions for PTSD and complex trauma
- The therapist’s role in preparation and post-experience integration
- Ethical, legal, and practice considerations when navigating client interest in these experiences
- How to speak with clients about psychedelic-based approaches in a responsible manner
[1]https://pmc.ncbi.nlm.nih.gov/articles/PMC9710723/
Meet the Speakers
Fede Menapace
Beckley Retreats Chief Growth Officer. Former COO at MAPS, Fede worked on developing innovative treatments for PTSD.
Manuela Mischke Reed
Founder of Embodywise and Co-Director of Hakomi Institute California. Expert in mind-body psychology.
Kosu Boudreau
Beckley Retreats Lead Facilitator. Kosu is a registered trauma psychotherapist and integration specialist.
Beckley Retreats Was Featured In
Beckley Retreats Team Member Affiliations